KFH - ANTIOCH
1. Target Overview & Investment Thesis
KFH - ANTIOCH is a 144-bed suburban community hospital in CONTRA COSTA, CA with $445.4M in net patient revenue and a 8.1% operating margin. The hospital serves a payer mix of 6.5% Medicare, 7.9% Medicaid, and 85.6% commercial.
Thesis: Turnaround. Our ML models identify $32.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.1% to 15.4% (+736bps).
| Net Revenue HCRIS | $445.4M |
| Current EBITDA COMPUTED | $35.9M |
| Operating Margin COMPUTED | 8.1% |
| Occupancy HCRIS | 67.8% |
| Revenue / Bed COMPUTED | $3.1M |
| Net-to-Gross HCRIS | 27.1% |
| Distress Probability ML | 41.1% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 8.1% places it above the state median. Among 200 size-comparable peers (72-288 beds), the median margin is -3.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (72-288), prioritizing same-state peers. 200 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| KFH - ANTIOCH (Target) | CA | 144 | $445.4M | 8.1% |
| CITY OF HOPE NATIONAL MEDICAL | CA | 217 | $1.83B | -10.7% |
| CALIFORNIA PACIFIC MEDICAL CEN | CA | 274 | $987.8M | -18.5% |
| ZUCKERBERG SAN FRANCISCO GENER | CA | 284 | $889.5M | -41.7% |
| SANTA MONICA UCLA MEDICAL CENT | CA | 281 | $835.9M | 2.8% |
| ENLOE MEDICAL CENTER | CA | 258 | $834.4M | -0.5% |
| KFH - SOUTH SACRAMENTO | CA | 233 | $803.9M | 5.9% |
| COMMUNITY HOSP. MONTEREY PENIN | CA | 227 | $797.2M | 9.3% |
| KFH - MANTECA | CA | 213 | $796.8M | 15.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $32.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $9.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $8.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $8.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $5.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $285K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $35.9M |
| + RCM Uplift | +$32.8M |
| Pro Forma EBITDA | $68.7M |
| Current Margin | 8.1% |
| Pro Forma Margin | 15.4% |
| WC Released (1x) | $17.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $55.2M | $564.7M | 10.22x | 59.2% |
| Base (11x exit) | 10.0x | 11.0x | $55.2M | $639.2M | 11.57x | 63.2% |
| Bull Case | 9.0x | 11.0x | $49.7M | $765.3M | 15.39x | 72.8% |
| Bull (12x exit) | 9.0x | 12.0x | $49.7M | $849.6M | 17.09x | 76.4% |
| Bear Case | 11.0x | 10.0x | $60.8M | $382.9M | 6.30x | 44.5% |
| Bear (11x exit) | 11.0x | 11.0x | $60.8M | $440.9M | 7.26x | 48.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 200 hospitals with 72-288 beds
- Same-state prioritization (n=201)
- Comp margins: P25=-17.9% / P50=-3.9% / P75=4.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.